Skip to Content on Nemours.org

You're location is

Refer a Patient
Research
Professional Education
Careers
GIVING
NEMOURS APP

Find a Doctor
Find a Location
Services & Specialties
Conditions
Well Beyond Medicine

Find a Doctor
Find a Location

Get Care
What We Treat
- Services & Specialties
- Conditions & Treatments
SEE SOMEONE RIGHT AWAY
- Urgent Care
- Video Visits

Patient & Family Resources

COVID-19 Information
Insurance We Accept
Financial Assistance
Nemours App
Support Services
International Medicine

Online Bill Pay Paying a bill online is easy and secure.
KidsHealth Library Healthy living resources for parents and children.

Health Professionals

Referring Physicians
Research & Clinical Trials
Professional Education
Residencies & Fellowships
NemoursLink

Giving & Volunteering

Volunteer
- Make a Gift 100 percent of every donation goes towards patient care, support and research.

Well Beyond Medicine

Social Determinants of Health
Thought Leadership
Asthma Prevention
Early Care & Education

Nemours App Easy, secure access to your child’s medical records, appointment reminders and more.

Login

Home
Find a Researcher
Darcy Hamill, DO

Darcy Hamill, DO

Physician

Provider Profile

Nemours Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803

Education & Training

Fellowship

Pediatric Hematology/Oncology - Nemours/Alfred I. duPont Hospital for Children, 2020

Internship Residency

Pediatrics - New York Medical College / Westchester Medical Ctr, 2017

Board Certifications

American Board of Pediatrics/Hematology-Oncology
American Board of Pediatrics/General Pediatrics

Cancer Biomarkers and Therapeutics

Gopalakrishnapillai, A., Correnti, C. E., Pilat, K., Lin, I., Chan, M. K., Bandaranayake, A. D., & Barwe, S. P. (2021). Immunotherapeutic targeting of mesothelin positive pediatric aml using bispecific t cell engaging antibodies. Cancers, 13(23). doi:10.3390/cancers13235964
Kinnaman, Hamill, D., Yabe, M., Powell, J., Benhamida, J., Hasselblatt, M., & Shukla, N. (2020). Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1. JCO Precision Oncology, 4, 1280-1284. doi:10.1200/PO.20.00215

WHO WE ARE

About Us
Leadership & Governance
Awards & Recognition
Policy & Prevention
Nemours 2020 Annual Report

LEGAL & PRIVACY

Web Privacy Policy
Terms of Use
Notice of Privacy Practices
Notice of Nondiscrimination & Language Accessibility
GDPR Privacy Notice
No Surprises Act
Hospital Visitation Policy

NEMOURS WEBSITES

KidsHealth
Healthy Kids, Healthy Future
Moving Health Care Upstream
Reading BrightStart
Nemours Blog

Health Professionals
Careers
Giving & Volunteering
International
Newsroom
Nemours Associates
Contact Us

Facebook
Twitter
Instagram
Pinterest
Linkedin
Youtube

© 2022. The Nemours Foundation. Nemours® is a registered trademark of The Nemours Foundation. All rights reserved.

Choose a Region

Nemours has a number of service regions. Selecting your region will help us show you the right contact information and the most relevant content for you.